Show Summary Details
Page of

Management of Treatment-Resistant Schizophrenia 

Management of Treatment-Resistant Schizophrenia
Chapter:
Management of Treatment-Resistant Schizophrenia
Author(s):

Jacob S. Ballon

and Jeffrey A. Lieberman

DOI:
10.1093/med/9780199739981.003.0011
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 25 November 2017

Schizophrenia continues to be among the most disabling disorders in psychiatry, and it often requires several attempts at treatment before finding the right regimen. Prognostic factors such as age of onset, types of symptoms, and treatment patterns can be influential in the overall outcome. The goal of treatment in schizophrenia should be to achieve recovery from the illness, beyond just amelioration of hallucinations or delusions. This often requires pharmacotherapy, nonmedication somatic therapies, psychotherapy, and other treatment modalities. Often in the course of schizophrenia, other psychiatric comorbidities are present and can influence the plan for care. For those who do not recover with the first few attempts at treatment, this chapter provides a review of evidence-based techniques and other ideas for clinicians to use with patients to achieve the best clinical response.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.